Occupational Exposure and Risk Assessment of Formaldehyde in the Pathology Departments of Hospitals.


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 May 2020
Historique:
received: 19 10 2019
entrez: 28 5 2020
pubmed: 28 5 2020
medline: 7 2 2021
Statut: epublish

Résumé

Exposure to formaldehyde has adverse effects on health both acutely and over the long term (e.g., carcinogenicity). The substance is widely used in pathology and histology departments.  This study focused on cancer risk of formaldehyde in pathology department of five hospitals in Rasht. Sampling and determination of formaldehyde in pathology department were carried out based on the NIOSH method of 3500. The working condition and working environment were investigated and a semi quantitative risk assessment were used to health risk assessment of formaldehyde and The individual lifetime cancer probability, which is defined as the increase in the probability of developing cancer during continuous exposure to an air pollutant were used to assess health risks with formaldehyde. The results showed that the exposure level of all subjects were higher than the Occupational Exposure Limit for 8 hours exposure time of formaldehyde. However, in the five occupational groups, the highest weekly exposure index was observed for the Lab Technicians (0.664 ppm) at Hospital no. 5, which could have been due to more daily working hours at this sampling site and a lack of adequate ventilation. The formaldehyde concentration was in the 0.0192 to 0.326 ppm ranges for five hospital pathology departments. The cancer risk ranged from 9.52×10-5 to 1.53×10-3, and it was greater than the WHO acceptable cancer risk level. The results of the risk assessments can be used for managing the chemical exposure of allocated resources for defining control actions. This process plays an important role in reducing the level of exposure to formaldehyde in pathology departments.<br />.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
Exposure to formaldehyde has adverse effects on health both acutely and over the long term (e.g., carcinogenicity). The substance is widely used in pathology and histology departments.  This study focused on cancer risk of formaldehyde in pathology department of five hospitals in Rasht.
MATERIALS AND METHODS METHODS
Sampling and determination of formaldehyde in pathology department were carried out based on the NIOSH method of 3500. The working condition and working environment were investigated and a semi quantitative risk assessment were used to health risk assessment of formaldehyde and The individual lifetime cancer probability, which is defined as the increase in the probability of developing cancer during continuous exposure to an air pollutant were used to assess health risks with formaldehyde.
RESULTS RESULTS
The results showed that the exposure level of all subjects were higher than the Occupational Exposure Limit for 8 hours exposure time of formaldehyde. However, in the five occupational groups, the highest weekly exposure index was observed for the Lab Technicians (0.664 ppm) at Hospital no. 5, which could have been due to more daily working hours at this sampling site and a lack of adequate ventilation. The formaldehyde concentration was in the 0.0192 to 0.326 ppm ranges for five hospital pathology departments. The cancer risk ranged from 9.52×10-5 to 1.53×10-3, and it was greater than the WHO acceptable cancer risk level.
CONCLUSIONS CONCLUSIONS
The results of the risk assessments can be used for managing the chemical exposure of allocated resources for defining control actions. This process plays an important role in reducing the level of exposure to formaldehyde in pathology departments.<br />.

Identifiants

pubmed: 32458637
doi: 10.31557/APJCP.2020.21.5.1303
pmc: PMC7541887
pii:
doi:

Substances chimiques

Disinfectants 0
Formaldehyde 1HG84L3525

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1303-1309

Références

Int Arch Occup Environ Health. 2012 May;85(4):389-96
pubmed: 21785865
Ann Occup Hyg. 2011 May;55(4):421-35
pubmed: 21320948
Environ Sci Pollut Res Int. 2011 Aug;19(7):2813-9
pubmed: 22322292
Environ Monit Assess. 2017 Apr;189(4):171
pubmed: 28321678
J Occup Environ Med. 2017 May;59(5):467-473
pubmed: 28486343
Regul Toxicol Pharmacol. 2005 Dec;43(3):232-48
pubmed: 16185798
Chem Rev. 2010 Apr 14;110(4):2536-72
pubmed: 20067232
Toxicol Ind Health. 2011 Aug;27(7):591-8
pubmed: 21357637
Iran J Public Health. 2010;39(4):26-34
pubmed: 23113035
J Occup Med Toxicol. 2010 Aug 20;5(1):25
pubmed: 20727169
Arch Toxicol. 2011 Oct;85(10):1295-302
pubmed: 21360194
Mutat Res. 2006 Jun 16;605(1-2):30-41
pubmed: 16584911
Environ Sci Pollut Res Int. 2006 Mar;13(2):120-4
pubmed: 16612901
Ind Health. 2005 Oct;43(4):703-7
pubmed: 16294927
Ann N Y Acad Sci. 2006 Sep;1076:635-48
pubmed: 17119241
J Neurosci Methods. 1997 Mar;72(1):65-70
pubmed: 9128170
Int J Occup Med Environ Health. 2011 Mar;24(1):108-13
pubmed: 21468908
Cancer Detect Prev. 2008;32(2):121-6
pubmed: 18639989
Mutat Res. 2002 Feb 15;514(1-2):115-23
pubmed: 11815250
Occup Environ Med. 2011 May;68(5):375-8
pubmed: 21097949
Mutat Res. 2012 May 15;744(2):161-6
pubmed: 22405975
Occup Med (Lond). 2018 Jun 20;68(5):307-313
pubmed: 29668989
Mutagenesis. 2015 Jul;30(4):463-73
pubmed: 25711496
Ann Occup Hyg. 2016 Jan;60(1):132-8
pubmed: 26342091
Toxicol Res (Camb). 2016 Apr 26;5(4):1122-1129
pubmed: 30090418
J Occup Health. 2012;54(1):74-8
pubmed: 22186296
Scand J Work Environ Health. 2013 Nov;39(6):618-30
pubmed: 23525098

Auteurs

Elham Yahyaei (E)

Department of Occupational Health, School of Health, Guilan University of Medical Sciences, Rasht, Iran.

Behzad Majlesi (B)

Department of Management, West Tehran Branch-Islamic Azad University, Tehran, Iran.

Mohammad Naimi Joubani (M)

Department of Environmental Health Engineering, School of Health, Guilan University of Medical Sciences, Rasht, Iran.

Yasaman Pourbakhshi (Y)

Institute of Medical Advanced Technologies, Guilan University of Medical Sciences, Rasht, Iran.

Samira Ghiyasi (S)

Department of Environmental Engineering, Central Tehran Branch, Islamic Azad University, Tehran, Iran.

Mehdi Jamshidi Rastani (M)

Department of Occupational Health, School of Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mahmoud Heidari (M)

Department of Occupational Health, School of Health, Guilan University of Medical Sciences, Rasht, Iran.
Research Center of Health and Environment, Guilan University of Medical Sciences, Rasht, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH